Mednow Achieves Record Q2 2023 Financial Results with Quarterly Revenue of $11.3 Million; 17% Q/Q Revenue Growth and 466% Y/Y Revenue Growth; Adjusted EBITDA Improved 32% Y/Y; and Cash Flow from Operations Improved by 7% Q/Q

Show full article

This functionality is available for registred users only

• Full name
  Dexcom, Inc.
• Registration country
  USA
• Industry
  Medical Devices
• М/S&P/F
  *** / *** / ***